LOS ANGELES--(BUSINESS WIRE)--Non-invasive cardiac assessment company Sensydia today announced it has raised approximately $8M in new funding from an expanded syndicate of investors. Proceeds of the ...

As a patient with a family history of heart disease, Karen Moore has always been diligent about monitoring her heart health. When her primary care doctor heard something unusual during a routine ...

McLaren Macomb in Mount Clemens has opened its upgraded cardiac catheterization lab after a $1.2 million renovation.

CLEVELAND, Ohio — A new cardiac catheterization laboratory in Willoughby is making it possible for heart patients in Lake County to stay close to home while getting minimally invasive treatments as ...

Health: Sensydia’s noninvasive cardiac assessment platform on a patient. Westwood-based Sensydia Corp., which is developing a non-invasive cardiac assessment platform, has received a $3 million grant ...

Trial findings suggest that the less invasive approach to heart bypass surgery offers comparable safety and efficacy to established methods and that safety issues inherent to invasive catheterisation ...

Cardiovascular disease is the leading cause of morbidity, and preclinical investigations of animal models are critical for better understanding its mechanisms. Over the last several decades, ...

About Cardiac Biotech Solutions Inc. Cardiac Biotech Solutions, Inc. engages in the provision of products and services in the ambulatory non-invasive cardiac monitoring space. The firm's FDA and CE ...